BioCentury
ARTICLE | Clinical News

Prevencio's HART PAD test detects PAD in diabetes patients

August 31, 2018 6:27 PM UTC

Prevencio Inc. (Kirkland, Wash.) said its HART PAD test diagnosed peripheral artery disease (PAD) in a cohort of 94 diabetic patients with 95% accuracy. Data were presented at the European Society of Cardiology meeting in Munich.

The study included a prospective cohort of 354 patients with and without diabetes undergoing peripheral and/or coronary angiography who were enrolled in Massachusetts General Hospital's Catheter Sampled Blood Archive in Cardiovascular Disease (CASABLANCA) study. The company said the results in patients with diabetes were comparable to patients without diabetes...

BCIQ Company Profiles

Prevencio Inc.